Medical Devices: Page 22
-
Natalie Meepian via Getty Images
Medtech venture capital investing rebounded in Q1
Pitchbook analysts are cautiously optimistic that the funding pickup will continue despite uncertainty about interest rates, heightened regulatory scrutiny and the presidential election.
By Susan Kelly • June 3, 2024 -
Retrieved from Steris on June 20, 2023
Steris to lay off employees in restructuring
Steris said it would cut “less than 300 positions” as it consolidates facilities, continuing the trend of medtechs laying off employees to save costs or reorganize businesses.
By Susan Kelly • May 31, 2024 -
Explore the Trendlineâž”
Sitthiphong via Getty Images
TrendlineMedical device industry continues to turn to AI
While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.
By MedTech Dive staff -
Permission granted by Akili Interactive
Digital therapeutics firm Akili to sell for $34M
Akili, which makes a video game treatment for ADHD, will merge with Virtual Therapeutics to create a larger digital health entity.
By Elise Reuter • May 30, 2024 -
Courtesy of Fresenius
Fresenius Medical Care plans layoffs ahead of California plant closure
More than 300 people will be affected as the company shifts dialysis manufacturing to a facility in Mexico.
By Elise Reuter • May 30, 2024 -
Permission granted by Medtronic
Medtronic elevates Linnea Burman to president of neurovascular unit
Burman will oversee strategy, product development and financial performance for a unit focused on stroke care.
By Susan Kelly • May 29, 2024 -
Patrik Stollarz / Staff via Getty Images
Philips reports 7 deaths linked with BiPAP alarm problem
Philips recalled three BiPAP models because an alarm can incorrectly engage and shut down the ventilator under certain circumstances.
By Elise Reuter • May 29, 2024 -
Permission granted by Otsuka Precision Health
Otsuka defies digital health downturn with new company
With “no playbook out there” to fall back on, the new company is taking a long-term approach as it develops its portfolio, an Otsuka Precision Health exec told MedTech Dive.
By Elise Reuter • May 29, 2024 -
Permission granted by Johnson & Johnson
Q&AJ&J’s Nisha Johnson on Ethizia wound-sealing patch, biosurgery market
With the recent launch of the hemostatic healing patch in Europe, J&J expects to lead the biosurgery and wound closure market.
By Elise Reuter • May 28, 2024 -
Courtesy of Intuitive Surgical
New products take center stage in medtech’s latest earnings season
From pulsed field ablation devices to Intuitive's latest da Vinci robot, product launches dominated recent earnings calls.
By Ricky Zipp • May 28, 2024 -
Ramberg via Getty Images
UK regulator proposes recognizing overseas medical device approvals
Companies with authorization in certain regions, including the EU and U.S., would be able to use their approvals to access Great Britain’s market.
By Nick Paul Taylor • May 24, 2024 -
Courtesy of Medtronic
Medtronic touts demand for PFA, adding to hype for the new ablation tech
CEO Geoff Martha told investors there has already been “strong adoption” of PFA devices and the category will be a big part of Medtronic's revenue growth in fiscal year 2025.
By Ricky Zipp • May 23, 2024 -
Retrieved from Hologic on May 23, 2024
Hologic recalls more than 53,000 radiographic markers linked to 71 injuries
The Biozorb devices are staying on the market, but Hologic has asked people to report adverse events such as pain.
By Nick Paul Taylor • May 23, 2024 -
Courtesy of Cue Health Press Kit
Cue Health to lay off remaining employees, shut down
Once a COVID-testing darling, Cue will close after raising hundreds of millions of dollars and striking high-profile partnerships with Google and the NBA during the pandemic.
By Elise Reuter • May 22, 2024 -
Courtesy of Tandem Diabetes Care
Medicare adviser sets recommendations for diabetes device evidence
A MEDCAC panel found time in range was an “extremely important” metric, but members were divided on whether quality of life measures should influence coverage.
By Elise Reuter • May 22, 2024 -
Carl Court via Getty Images
EMA updates advice on drug-device combinations under MDR, IVDR
The European Medicines Agency answered six new questions to clarify topics such as how companies can get advice on borderline products.
By Nick Paul Taylor • May 22, 2024 -
Courtesy of H2O Therapeutics
FDA seeks AI tech to predict, detect Parkinson’s symptoms
By testing artificial intelligence and machine learning models, the agency hopes to come up with best practices for Parkinson’s measures from wearables and smartphones.
By Elise Reuter • May 21, 2024 -
Courtesy of Medtronic
Medtronic heads into earnings having seen rivals prosper
J.P. Morgan and RBC analysts are expecting updates on several key markets on Medtronic's Q4 call, including surgical robotics and pulsed field ablation.
By Nick Paul Taylor • May 21, 2024 -
Courtesy of Boston Scientific
Boston Scientific’s cardiac rhythm system hits pivotal trial goals
Boston Scientific, which presented the results at the Heart Rhythm Society meeting, expects to receive FDA approval for the system in 2025.
By Nick Paul Taylor • May 21, 2024 -
Courtesy of Medtronic
Pulsed field ablation poised for fast adoption, analysts say
Feedback from the Heart Rhythm Society meeting suggests 50% to 70% of physicians could adopt the procedure “right out of the gate,” said Truist analyst Richard Newitter.
By Susan Kelly • May 20, 2024 -
Courtesy of Boston Scientific
UK backs use of cancer treatment offered by Boston Scientific
A Boston Scientific executive said the guidance will expand access to a minimally invasive treatment for tumors that have metastasized to the liver.
By Nick Paul Taylor • May 20, 2024 -
Courtesy of Johnson & Johnson
J&J posts latest Varipulse data while awaiting FDA review
Johnson & Johnson is chasing Medtronic and Boston Scientific in the U.S. for a share of the rapidly growing pulsed field ablation market.
By Nick Paul Taylor • May 20, 2024 -
Getty Images via Getty Images
Pulse Biosciences names new CEO, reassigns former leader
Burke Barrett will take over the role effectively immediately, while former CEO Kevin Danahy will become the chief commercial officer.
By Nick Paul Taylor • May 17, 2024 -
Sara Silbiger via Getty Images
FDA issues import alerts against 2 more plastic syringe manufacturers
Officials moved to stop the plastic syringes made by two Chinese manufacturers from entering the U.S. after finding quality system failings.
By Nick Paul Taylor • May 17, 2024 -
Permission granted by Becton Dickinson
BD wins FDA approval for cervical cancer screening self-collection kit
Patients can self-collect the samples in locations such as retail pharmacies, which could encourage more people to get tested.
By Nick Paul Taylor • May 17, 2024 -
Courtesy of Dexcom
Dexcom details plans for over-the-counter CGM as insulin pump firms seek Type 2 coverage
Diabetes tech companies shared updates on new products, largely focused on Type 2 patients, in Q1 earnings calls.
By Elise Reuter • May 16, 2024
Previous
